We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Shares of Abbott Laboratories ABT slumped 0.79% to $116.80 Wednesday, on what proved to be an all-around great trading ...

Abbott Laboratories beat Wall Street estimates for quarterly earnings and sales. The maker of healthcare products posted ...

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...

That's a massive long-term opportunity. Abbott Laboratories is also an excellent dividend stock, currently on a streak of 52 consecutive payout increases. If you opt to reinvest the dividend ...

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant which was at center of a nationwide formula shortage in 2022. Abbott is recalling several of its ready ...

Investors happily greeted the latest news from Abbott Laboratories (NYSE: ABT) on Hump Day. After the storied healthcare company unveiled its third-quarter results, those folks traded its stock up ...

After the verdict and the "overwhelming societal support of infant formula, we think its prudent to lower the liability ...

The adjustment follows a favorable verdict for Abbott in a recent NEC lawsuit in St. Louis. The analyst from Barclays indicated that despite the stock's recent gains, including an 18% rise from its ...